Technical Analysis for MNOV - MediciNova, Inc.

Grade Last Price % Change Price Change
C 3.92 0.51% 0.02
MNOV closed up 0.51 percent on Friday, September 17, 2021, on 49 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down
Historical MNOV trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Fell Below 20 DMA Bearish 0.51%
MACD Bearish Signal Line Cross Bearish 0.51%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.51%
20 DMA Support Bullish -1.75%
Inside Day Range Contraction -1.75%
20 DMA Support Bullish -0.51%
Doji - Bearish? Reversal -5.08%
Up 3 Days in a Row Strength -5.08%
Up 4 Days in a Row Strength -5.08%
Older End-of-Day Signals for MNOV ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

MediciNova, Inc. Description

MediciNova, Inc., a development stage biopharmaceutical company, focuses on acquiring and developing small molecule therapeutics for the treatment of serious diseases for the United States market. The company's principal product candidates include MN-166, an ibudilast-based drug candidate, which is in Phase I and Phase II clinical trials for the treatment of drug dependence and pain; and MN-221, a ß2 -adrenergic receptor agonist that has completed Phase II clinical trials for the treatment of acute exacerbations of asthma. It also has other product candidates in the clinical development for the treatment of acute exacerbations of asthma, multiple sclerosis and other central nervous system disorders, bronchial asthma, interstitial cystitis, solid tumor cancers, generalized anxiety disorders/insomnia, preterm labor, urinary incontinence, and thrombotic disorders. MediciNova, Inc. was founded in 2000 and is headquartered in La Jolla, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Development Pain Medication Multiple Sclerosis Respiratory Therapy Asthma Nervous System Disorders Central Nervous System Disorders Serious Diseases Molecule Therapeutics Pulmonology Solid Tumor Cancers Insomnia Urinary Incontinence Treatment Of Serious Diseases Bronchial Asthma Interstitial Cystitis

Is MNOV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.81
52 Week Low 3.34
Average Volume 186,709
200-Day Moving Average 4.79
50-Day Moving Average 3.77
20-Day Moving Average 3.94
10-Day Moving Average 4.03
Average True Range 0.17
ADX 24.8
+DI 21.95
-DI 18.87
Chandelier Exit (Long, 3 ATRs) 3.82
Chandelier Exit (Short, 3 ATRs) 3.93
Upper Bollinger Bands 4.28
Lower Bollinger Band 3.59
Percent B (%b) 0.48
BandWidth 17.71
MACD Line 0.07
MACD Signal Line 0.08
MACD Histogram -0.0144
Fundamentals Value
Market Cap 176.12 Million
Num Shares 44.9 Million
EPS -0.37
Price-to-Earnings (P/E) Ratio -10.65
Price-to-Sales 0.00
Price-to-Book 3.62
PEG Ratio -0.94
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.08
Resistance 3 (R3) 4.08 4.04 4.05
Resistance 2 (R2) 4.04 4.00 4.03 4.04
Resistance 1 (R1) 3.98 3.97 3.97 3.97 4.03
Pivot Point 3.93 3.93 3.93 3.93 3.93
Support 1 (S1) 3.87 3.89 3.87 3.87 3.81
Support 2 (S2) 3.83 3.87 3.82 3.80
Support 3 (S3) 3.77 3.83 3.79
Support 4 (S4) 3.76